Beatrix Metzner

Company: Boehringer Ingelheim
Beatrix

Dr. Beatrix Metzner studied chemistry at the University of Regensburg and the Albert-Ludwigs-University of Freiburg where she was specialized in biochemistry. Furthermore she was PhD student at the Department of Experimental Dermatology at the University of Freiburg and Post Doctoral research Fellow at the Memorial Sloan-Kettering Cancer Center (Immunology Program) in New York (Research fellowship of the German Research Society).From 2000 she worked at MediGene AG as Senior Scientist, later Manager Operations and Senior CMC Project Manager. In 2005 she started to work at Merck KGaA as Project Manager (CMC - Bio-manufacturing/Protein Supply).In 2007 she moved to Global Regulatory Oncology where she has been working as Director Global Regulatory Oncology since November 2008. Since November 2013 she took over the position as Head of Global Regulatory CMC Strategy Biosimilars at Boehringer Ingelheim.